{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:45:06Z","timestamp":1791981906896,"version":"4.4.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Princess Beatrix Foundation for Neuromuscular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.nmd.2025.105274","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:54:44Z","timestamp":1736423684000},"page":"105274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Muscle imaging in facioscapulohumeral muscular dystrophy research: A scoping review and expert recommendations"],"prefix":"10.1016","volume":"47","author":[{"given":"Sanne C\u2024C\u2024","family":"Vincenten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-2182","authenticated-orcid":false,"given":"Sjan","family":"Teeselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Heskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermien E\u2024","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Heerschap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnie","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris G\u2024","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C\u2024","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G\u2024M\u2024","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nens","family":"van Alfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nmd.2025.105274_bib0001","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0002","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.23949","article-title":"Risk of functional impairment in Facioscapulohumeral muscular dystrophy","volume":"49","author":"Statland","year":"2014","journal-title":"Muscle Nerve"},{"issue":"5999","key":"10.1016\/j.nmd.2025.105274_bib0003","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nmd.2013.07.009","article-title":"Clinical trial preparedness in facioscapulohumeral dystrophy: outcome measures and patient access: 8-9 April 2013, Leiden, The Netherlands","volume":"24","author":"Tawil","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","article-title":"265th ENMC International Workshop: muscle imaging in Facioscapulohumeral muscular dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands","volume":"33","author":"Monforte","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105274_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2023.04.005","article-title":"268th ENCM workshop - genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials","author":"Montagnese","year":"2023","journal-title":"Neuromusc Disorders"},{"key":"10.1016\/j.nmd.2025.105274_bib0007","unstructured":"U.S. Food and Drug Administration. About Biomarkers and Qualification. Accessed 2023 https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/about-biomarkers-and-qualification#:~:text=A%20biomarker%20is%20not%20an,feels%2C%20functions%2C%20or%20survives.&text=BEST%20defines%20seven%20biomarker%20categories,pharmacodynamic%2Fresponse%2C."},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0008","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2019.09.003","article-title":"Measurement properties and utility of performance-based outcome measures of physical functioning in individuals with facioscapulohumeral dystrophy - a systematic review and evidence synthesis","volume":"29","author":"de Valle","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0009","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mus.26064","article-title":"Magnetic resonance imaging in facioscapulohumeral muscular dystrophy","volume":"57","author":"Leung","year":"2018","journal-title":"Muscl Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.nmd.2025.105274_bib0011","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2014.05.012","article-title":"Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement","volume":"24","author":"Rijken","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.27081","article-title":"Muscle ultrasound: present state and future opportunities","volume":"63","author":"Wijntjes","year":"2021","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12883-019-1452-x","article-title":"Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study","volume":"19","author":"LoRusso","year":"2019","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2025.105274_bib0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nmd.2025.105274_bib0015","unstructured":"Radboudumc library guide medical sciences: literature search. Accessed 18-10-2023. https:\/\/libguides.ru.nl\/medical\/literaturesearch."},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0016","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00415-021-10786-1","article-title":"Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning","volume":"269","author":"Monforte","year":"2022","journal-title":"J Neurol"},{"issue":"20","key":"10.1016\/j.nmd.2025.105274_bib0017","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1212\/WNL.0000000000004647","article-title":"Adding quantitative muscle MRI to the FSHD clinical trial toolbox","volume":"89","author":"Mul","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2025.105274_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132717","article-title":"Muscle quantitative MR imaging and clustering analysis in patients with facioscapulohumeral muscular dystrophy type 1","volume":"10","author":"Lareau-Trudel","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib0019","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00330-015-3890-1","article-title":"Muscle MRI findings in facioscapulohumeral muscular dystrophy","volume":"26","author":"Gerevini","year":"2016","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00062-015-0386-y","article-title":"Clinical muscle testing compared with whole-body magnetic resonance imaging in facio-scapulo-humeral muscular dystrophy","volume":"26","author":"Regula","year":"2016","journal-title":"Clin Neuroradiol"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0021","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.24569","article-title":"Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy","volume":"52","author":"Leung","year":"2015","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0022","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00415-006-0230-z","article-title":"Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI","volume":"253","author":"Olsen","year":"2006","journal-title":"J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2025.105274_bib0023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000452763","article-title":"Leg muscle involvement in facioscapulohumeral muscular dystrophy: comparison between facioscapulohumeral muscular dystrophy types 1 and 2","volume":"77","author":"Mair","year":"2017","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0024","doi-asserted-by":"crossref","first-page":"e85416","DOI":"10.1371\/journal.pone.0085416","article-title":"Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration","volume":"9","author":"Janssen","year":"2014","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.nmd.2025.105274_bib0025","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/WNL.0000000000000828","article-title":"Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy","volume":"83","author":"Dahlqvist","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0026","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.22342","article-title":"The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy","volume":"45","author":"Friedman","year":"2012","journal-title":"Muscl Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0027","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00415-010-5858-z","article-title":"Camptocormia phenotype of FSHD: a clinical and MRI study on six patients","volume":"258","author":"Jordan","year":"2011","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib0028","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nmd.2017.11.017","article-title":"Specific muscle strength is reduced in facioscapulohumeral dystrophy: an MRI based musculoskeletal analysis","volume":"28","author":"Marra","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2025.105274_bib0029","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.nmd.2016.04.012","article-title":"A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)","volume":"26","author":"Petek","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.1016\/j.nmd.2025.105274_bib0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.clinbiomech.2014.07.008","article-title":"Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy","volume":"29","author":"Rijken","year":"2014","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0031","first-page":"67","article-title":"Can MRI imaging of a muscle set follow FSHD natural history? [Conference Abstract]","volume":"35","author":"Scarlato","year":"2016","journal-title":"Acta Myologica"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0032","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ana.24640","article-title":"Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials","volume":"79","author":"Tasca","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100292","article-title":"Upper girdle imaging in facioscapulohumeral muscular dystrophy","volume":"9","author":"Tasca","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib0034","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2214\/ajr.146.3.565","article-title":"MRI of normal and pathologic skeletal muscle","volume":"146","author":"Murphy","year":"1986","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nmd.2009.02.009","article-title":"Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy","volume":"19","author":"Kan","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0036","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s43856-022-00217-1","article-title":"Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy","volume":"2","author":"Heskamp","year":"2022","journal-title":"Commun Med (Lond)"},{"issue":"12","key":"10.1016\/j.nmd.2025.105274_bib0037","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/ene.14446","article-title":"Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging","volume":"27","author":"Giacomucci","year":"2020","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0038","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mus.27558","article-title":"Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy","volume":"66","author":"Statland","year":"2022","journal-title":"Muscl Nerve"},{"issue":"18 SUPPL","key":"10.1016\/j.nmd.2025.105274_bib0039","article-title":"Whole body MRI quantitative muscle analysis to evaluate Efficacy of Losmapimod in a phase 2 Placebo-controlled study in subjects with FSHD (ReDUX4)","volume":"98","author":"Mellion","year":"2022","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.nmd.2025.105274_bib0040","article-title":"Annualized rates of change from A phase 2, randomized, double-blind, placebo-controlled, 48-week study of losmapimod in Subjects with FSHD: reDUX4","volume":"100","author":"Tawil","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0041","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/jcsm.13250","article-title":"Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome","volume":"14","author":"Vincenten","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nmd.2025.105274_bib0042","article-title":"A 5-year natural history cohort of patients with facioscapulohumeral muscular dystrophy determining disease progression and feasibility of clinical outcome assessments for clinical trials","author":"Kools","year":"2024","journal-title":"Muscl Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nmd.2022.11.006","article-title":"Correlation between whole body muscle MRI and functional measures in paediatric patients with facioscapulohumeral muscular dystrophy","volume":"33","author":"Woodcock","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2025.105274_bib101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10875-010-9474-6","article-title":"CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI","volume":"31","author":"Frisullo","year":"2011","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.nmd.2025.105274_bib102","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinbiomech.2007.07.013","article-title":"Mobility assessment of patients with facioscapulohumeral dystrophy","volume":"22","author":"Iosa","year":"2007","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"13","key":"10.1016\/j.nmd.2025.105274_bib0048","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/hmg\/ddaa079","article-title":"PAX7 target gene repression associates with FSHD progression and pathology over 1 year","volume":"29","author":"Banerji","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.nmd.2025.105274_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183825","article-title":"Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study","volume":"12","author":"Fatehi","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib104","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00415-016-8361-3","article-title":"MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients","volume":"264","author":"Andersen","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2025.105274_bib105","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200757","article-title":"Quantitative muscle analysis in FSHD using whole-body fat-referenced MRI: composite scores for longitudinal and cross-sectional analysis","author":"Mellion","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2025.105274_bib0054","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mus.23911","article-title":"Longitudinal features of STIR bright signal in FSHD","volume":"49","author":"Friedman","year":"2014","journal-title":"Muscl Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib106","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mus.27074","article-title":"Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy","volume":"63","author":"Lassche","year":"2021","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib107","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-020-10254-2","article-title":"Quantitative (1)H and (23)Na muscle MRI in Facioscapulohumeral muscular dystrophy patients","volume":"268","author":"Gerhalter","year":"2021","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib108","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mus.26792","article-title":"Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy","volume":"61","author":"Hamel","year":"2020","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib109","doi-asserted-by":"crossref","first-page":"fcad221","DOI":"10.1093\/braincomms\/fcad221","article-title":"The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy","volume":"5","author":"Banerji","year":"2023","journal-title":"Brain Commun"},{"issue":"18","key":"10.1016\/j.nmd.2025.105274_bib110","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.0000000000002640","article-title":"Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients","volume":"86","author":"Janssen","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib111","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mus.26038","article-title":"MRI change metrics of facioscapulohumeral muscular dystrophy: stir and T1","volume":"57","author":"Ferguson","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib112","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jcsm.12473","article-title":"Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging","volume":"10","author":"Monforte","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0049","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12891-021-04134-7","article-title":"Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0043","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41598-022-04817-8","article-title":"Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers","volume":"12","author":"van den Heuvel","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib0044","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0045","doi-asserted-by":"crossref","first-page":"e38779","DOI":"10.1371\/journal.pone.0038779","article-title":"Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles","volume":"7","author":"Tasca","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0046","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/hmg\/ddaa031","article-title":"Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies","volume":"29","author":"Wong","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.105274_bib0047","article-title":"Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design","volume":"20","author":"Wong","year":"2023","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-019-09242-y","article-title":"Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy","volume":"266","author":"Dahlqvist","year":"2019","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2025.105274_bib0051","doi-asserted-by":"crossref","first-page":"e4691","DOI":"10.1002\/nbm.4691","article-title":"Baseline fat fraction is a strong predictor of disease progression in Becker muscular dystrophy","volume":"35","author":"Veeger","year":"2022","journal-title":"NMR Biomed"},{"issue":"15","key":"10.1016\/j.nmd.2025.105274_bib0052","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1212\/WNL.0000000000009244","article-title":"Modeling disease trajectory in Duchenne muscular dystrophy","volume":"94","author":"Rooney","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2025.105274_bib0053","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mus.27638","article-title":"Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: protocol development, multicenter feasibility, and repeatability","volume":"66","author":"Widholm","year":"2022","journal-title":"Muscl Nerve"},{"issue":"9","key":"10.1016\/j.nmd.2025.105274_bib0055","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1212\/WNL.0000000000010155","article-title":"Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy","volume":"95","author":"Dahlqvist","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0056","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/nbm.1494","article-title":"Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism","volume":"23","author":"Kan","year":"2010","journal-title":"NMR Biomed"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0057","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mus.26048","article-title":"Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy","volume":"57","author":"Leung","year":"2018","journal-title":"Muscl Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0058","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10334-017-0616-1","article-title":"Combined quantification of fatty infiltration, T (1)-relaxation times and T (2)*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients","volume":"30","author":"Leporq","year":"2017","journal-title":"Magma"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0059","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmpb.2015.03.006","article-title":"Computer-based assessment for facioscapulohumeral dystrophy diagnosis","volume":"120","author":"Chambers","year":"2015","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0060","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/s41598-020-59267-x","article-title":"Automated assessment of regional muscle volume and hypertrophy using MRI","volume":"10","author":"Mandi\u0107","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2025.105274_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1200727","article-title":"Automated MRI quantification of volumetric per-muscle fat fractions in the proximal leg of patients with muscular dystrophies","volume":"14","author":"Huysmans","year":"2023","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0062","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10334-020-00839-3","article-title":"Automated multi-atlas segmentation of gluteus maximus from Dixon and T1-weighted magnetic resonance images","volume":"33","author":"Belzunce","year":"2020","journal-title":"Magma"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0063","first-page":"128","article-title":"Deep learning-based thigh muscle segmentation for reproducible fat fraction quantification using fat-water decomposition MRI","volume":"11","author":"Ding","year":"2020","journal-title":"Insight Imag"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0064","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/mrm.29599","article-title":"Deep learning-based automatic pipeline for quantitative assessment of thigh muscle morphology and fatty infiltration","volume":"89","author":"Gaj","year":"2023","journal-title":"Magn Reson Med"},{"issue":"3","key":"10.1016\/j.nmd.2025.105274_bib0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10334-021-00967-4","article-title":"Deep learning for automatic segmentation of thigh and leg muscles","volume":"35","author":"Agosti","year":"2022","journal-title":"Magma"},{"issue":"2","key":"10.1016\/j.nmd.2025.105274_bib0066","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.220132","article-title":"A deep learning algorithm for automatic 3D segmentation of rotator cuff muscle and fat from clinical MRI scans","volume":"5","author":"Riem","year":"2023","journal-title":"Radiol Artif Intell"},{"issue":"7\u20138","key":"10.1016\/j.nmd.2025.105274_bib0067","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diii.2022.01.012","article-title":"A deep learning tool without muscle-by-muscle grading to differentiate myositis from facio-scapulo-humeral dystrophy using MRI","volume":"103","author":"Fabry","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.nmd.2025.105274_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109460","article-title":"Texture analysis and machine learning to predict water T2 and fat fraction from non-quantitative MRI of thigh muscles in Facioscapulohumeral muscular dystrophy","volume":"134","author":"Felisaz","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.nmd.2025.105274_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1105276","article-title":"Radiomics and machine learning applied to STIR sequence for prediction of quantitative parameters in facioscapulohumeral disease","volume":"14","author":"Colelli","year":"2023","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0071","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1038\/s41598-022-11147-2","article-title":"Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy","volume":"12","author":"Deligianni","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0072","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/mus.25619","article-title":"Bone health in facioscapulohumeral muscular dystrophy: a cross-sectional study","volume":"56","author":"Chagarlamudi","year":"2017","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0073","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jbspin.2011.05.006","article-title":"Decreased bone mineral density in adult patients with muscular dystrophy","volume":"78","author":"Philippe","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0074","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.48.1.46","article-title":"A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group","volume":"48","author":"Tawil","year":"1997","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.nmd.2025.105274_bib0075","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1212\/01.wnl.0000264017.08217.39","article-title":"Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy","volume":"68","author":"Elsheikh","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nmd.2025.105274_bib0076","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0077","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.nmd.2008.07.005","article-title":"The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD)","volume":"18","author":"Skalsky","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2025.105274_bib0078","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1139\/apnm-2020-1119","article-title":"Resting metabolic rate in adults with facioscapulohumeral muscular dystrophy","volume":"46","author":"Vera","year":"2021","journal-title":"Appl Physiol Nutr Metab"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0079","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1249\/MSS.0000000000002882","article-title":"Exercise intolerance in facioscapulohumeral muscular dystrophy","volume":"54","author":"Vera","year":"2022","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.nmd.2025.105274_bib0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphys.2020.01008","article-title":"Sarcopenic obesity in facioscapulohumeral muscular dystrophy","volume":"11","author":"Vera","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.nmd.2025.105274_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2023.06.008","article-title":"Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy","author":"Wang","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105274_bib0082","series-title":"Neurology. Conference: 74th Annual Meeting of the American Academy of Neurology, AAN","first-page":"98","article-title":"Dual energy X -ray absorptiometry to measure lean muscle massin FSHD","author":"Wang","year":"2022"},{"issue":"21","key":"10.1016\/j.nmd.2025.105274_bib0083","first-page":"e2103","article-title":"Natural history of facioscapulohumeral dystrophy in children","volume":"97","author":"Dijkstra","year":"2021","journal-title":"A 2-Year Follow-up"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0084","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/mus.24247","article-title":"Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy","volume":"50","author":"Janssen","year":"2014","journal-title":"Muscl Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2025.105274_bib0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.26717","article-title":"Respiratory muscle weakness in facioscapulohumeral muscular dystrophy","volume":"60","author":"Henke","year":"2019","journal-title":"Muscl Nerve"},{"key":"10.1016\/j.nmd.2025.105274_bib0086","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009211","article-title":"Muscle ultrasound is a responsive biomarker in FSHD","author":"Goselink","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0087","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s00415-018-9037-y","article-title":"Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers","volume":"265","author":"Mul","year":"2018","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105274_bib0088","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ane.13428","article-title":"Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy","volume":"144","author":"Veltsista","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"10.1016\/j.nmd.2025.105274_bib0089","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.nmd.2023.10.015","article-title":"Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy","volume":"33","author":"Vincenten","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0090","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1007\/s10072-023-06842-5","article-title":"Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients","volume":"44","author":"Fionda","year":"2023","journal-title":"Neurol Sci"},{"issue":"Supplement 1","key":"10.1016\/j.nmd.2025.105274_bib0091","first-page":"S128","article-title":"Muscle imaging in natural history of FSHD: quantitative MRI and ultrasound results compared head-to-head","volume":"33","author":"Vincenten","year":"2023","journal-title":"Neuromuscul Disorders"},{"key":"10.1016\/j.nmd.2025.105274_bib0092","series-title":"Neurology. Conference: American Academy Of Neurology Annual Meeting","article-title":"Muscle ultrasound in an open-label study of losmapimod in subjects with FSHD1","volume":"100","author":"Kools","year":"2023"},{"issue":"4","key":"10.1016\/j.nmd.2025.105274_bib0093","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.27943","article-title":"Three-dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy","volume":"68","author":"de Jong","year":"2023","journal-title":"Muscl Nerve"},{"issue":"11","key":"10.1016\/j.nmd.2025.105274_bib0094","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ultrasmedbio.2017.06.016","article-title":"Ultrasound imaging of muscle contraction of the tibialis anterior in patients with facioscapulohumeral dystrophy","volume":"43","author":"Gijsbertse","year":"2017","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14366\/usg.20080","article-title":"Artificial intelligence in musculoskeletal ultrasound imaging","volume":"40","author":"Shin","year":"2021","journal-title":"Ultrasonography"},{"issue":"9","key":"10.1016\/j.nmd.2025.105274_bib0096","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/j.ultrasmedbio.2015.04.021","article-title":"Advances in quantitative muscle ultrasonography using texture analysis of ultrasound images","volume":"41","author":"Molinari","year":"2015","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0097","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1038\/s41598-020-64287-8","article-title":"A quantitative method to assess muscle edema using short TI inversion recovery MRI","volume":"10","author":"Dahlqvist","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nmd.2025.105274_bib0098","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-160145","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials","volume":"3","author":"Carlier","year":"2016","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.nmd.2025.105274_bib0099","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jmri.28669","article-title":"New insights into the spread of MRS-based water T2 values observed in highly fatty replaced muscles","volume":"58","author":"Reyngoudt","year":"2023","journal-title":"J Magn Reson Imaging"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:37Z","timestamp":1778570557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662500001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":111,"alternative-id":["S096089662500001X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105274","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle imaging in facioscapulohumeral muscular dystrophy research: A scoping review and expert recommendations","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105274"}}